Valeant CEO Will Testify About Drug Prices Before Senate
Despite initial resistance, Valeant Pharmaceuticals International Inc.'s outgoing CEO J. Michael Pearson has agreed to comply with a U.S. Senate committee subpoena and testify about drug pricing, the committee said Wednesday,...To view the full article, register now.
Already a subscriber? Click here to view full article